Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
Clinical trial NCT02899078 · COMPLETED
Trial details
- NCT number
- NCT02899078
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2020-08-05
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.